07:00 , Apr 15, 2013 |  BC Week In Review  |  Company News

Techniclone management update

Techniclone Corp. (TCLN), Tustin, Calif.   Business: Cancer   Hired: John Bonfiglio, Ph.D., as VP of business development; formerly director of strategic business at Baxter Healthcare Corp.; Jamie Oliver, Pharm.D., as VP of clinical affairs;...
07:00 , Mar 11, 2013 |  BC Week In Review  |  Company News

Genmab, Baxter deal

Genmab sold its non-plasma-derived antibody manufacturing facility in Brooklyn Park, Minn., for about $10 million in cash to Baxter's Baxter Healthcare Corp. U.S. subsidiary, which acquired the facility, land and equipment at the site. Genmab...
07:00 , Apr 2, 2012 |  BC Week In Review  |  Company News

Durata Therapeutics management update

Durata Therapeutics Inc. , Morristown, N.J.   Business: Infectious   Hired: John Shannon as chief commercial officer, a newly created position, formerly general manager of global hemophilia and global commercial excellence at Baxter International Inc....
08:00 , Feb 4, 2008 |  BC Week In Review  |  Company News

Baxter sales and marketing update

Baxter's Baxter Healthcare Corp. subsidiary announced a voluntary recall of nine lots of 10 and 30 mL vials of heparin sodium because of an increase in reports of allergic-type reactions in patients who received the...
07:00 , Sep 10, 2007 |  BC Week In Review  |  Company News

BioSante management update

BioSante Pharmaceuticals Inc. (BPA), Lincolnshire, Ill.   Business: Drug delivery, Endocrine, Genitourinary   Hired: Joy Thomas as VP of corporate development, formerly senior director of global strategy and business development for the renal division at...
08:00 , Jan 1, 2007 |  BC Week In Review  |  Company News

Cerus, Baxter, BioOne Corp. deal

CERS received a $5 million cash milestone payment from BioOne under a 2005 deal to do market and distribute the Intercept Blood System for plasma in Asia (see BioCentury, June 13, 2005). The milestone was...
08:00 , Dec 4, 2006 |  BioCentury  |  Tools & Techniques

CD74 is MIF'd

A number of MIF inhibition programs have faltered, despite the fact that MIF is a well-characterized cytokine involved in inflammation and angiogenesis that may play a role similar to TNF alpha . Now that it...
07:00 , Jun 19, 2006 |  BC Week In Review  |  Company News

Amylin sales and marketing update

AMLN said it is asking physicians to limit prescriptions for Byetta exenatide because of a shortage of cartridges for the diabetes drug. The company had warned investors in April of a possible temporary shortage due...
07:00 , May 29, 2006 |  BC Week In Review  |  Company News

Acambis, Bavarian Nordic infectious news

ACM said it filed an opposition to BAVA's European Patent No. 1,335,987 covering BAVA's MVA-BN Modified Vaccinia Ankara (MVA) technology. ACM said that partner Baxter Healthcare Corp. (BAX, Deerfield, Ill.), which manufactures ACM's MVA3000 MVA...
08:00 , Mar 13, 2006 |  BC Week In Review  |  Company News

Orexigen management update

Orexigen Therapeutics Inc. , San Diego, Calif.   Business: Metabolic   Hired: Gary Tollefson as president and CEO, formerly president of Eli Lilly and Co.'s neuroscience product group; Anthony McKinney as COO, formerly SVP and...